Droperidol Use and Precautions

Introduction to Droperidol

Droperidol should be used only when first-line drugs are unsuccessful, with careful monitoring for QT prolongation and cardiovascular effects, particularly in high-risk patients 1
The American Gastroenterological Association recommends careful use of droperidol due to its potential for QT prolongation and risk of torsades de pointes 1

Droperidol is absolutely contraindicated in patients with pre-existing prolonged QTc interval (>440 ms in males, >450 ms in females) 1
The American Heart Association suggests that droperidol should be used with extreme caution or avoided in patients with a history of congestive heart failure, bradycardia, diuretic use, cardiac hypertrophy, electrolyte abnormalities, age >65 years, or alcohol abuse 1
Patients with a history of ventricular arrhythmias should not receive droperidol 1

Droperidol can cause extrapyramidal effects, including acute dystonia, akathisia, and Parkinsonian symptoms, as reported by the American Academy of Pediatrics 2 and the American Gastroenterological Association 1
The American Society of Anesthesiologists recommends monitoring for hypotension, as droperidol can cause peripheral vasodilation and hypotension, although the exact mechanism is not fully understood 1

The initial dose of droperidol for antiemetic therapy should be 1.25-2.5 mg IV, as recommended by the American Gastroenterological Association 1
For sedation in difficult-to-sedate patients, the dose should be 1.25-5.0 mg IV, with careful monitoring for QT prolongation and cardiovascular effects 1
The onset of action is 3-10 minutes after IV administration, and the duration of effect is 2-4 hours, according to the American Gastroenterological Association 1

For agitated but cooperative patients, a combination of oral benzodiazepine (lorazepam) and oral antipsychotic (risperidone) may be considered, as suggested by the American College of Emergency Physicians 3
For rapid sedation in difficult-to-sedate patients, consider parenteral benzodiazepine with haloperidol if droperidol is contraindicated, as recommended by the American College of Emergency Physicians 3

Immediate administration of IV magnesium sulfate (2g) is recommended for ventricular tachycardia, along with correction of any electrolyte abnormalities and discontinuation of all QT-prolonging medications, as suggested by the American Heart Association 3
Continuous cardiac monitoring is essential for patients receiving droperidol, particularly those with high-risk factors, as recommended by the American Gastroenterological Association 1